IP Verse

Pharmaceutical Compositions Comprising Botulinum Neurotoxin - EP2939688

The patent EP2939688 was granted to Ipsen Biopharm on Feb 20, 2019. The application was originally filed on Jul 6, 2005 under application number EP15000178A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2939688

IPSEN BIOPHARM
Application Number
EP15000178A
Filing Date
Jul 6, 2005
Status
Opposition Rejected
Apr 21, 2023
Grant Date
Feb 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALLERGANNov 20, 2019HOFFMANN EITLE -

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2003138437
EXAMINATIONUS2003224020
EXAMINATIONWO9407510
OPPOSITIONDE10333317
OPPOSITIONEP1931306
OPPOSITIONUS2002107199
OPPOSITIONUS2003118598
OPPOSITIONUS2003138437
OPPOSITIONUS2003224020
OPPOSITIONUS2007134199
OPPOSITIONWO0137656
OPPOSITIONWO0158472
OPPOSITIONWO2005007185
OPPOSITIONWO9611699
OTHEREP1817051
OTHERUS2002064536
OTHERUS2003118598
OTHERUS4457916
OTHERUS5733873
OTHERUS9125804
OTHERWO0158472
SEARCHUS2003118598
SEARCHUS2004033241
SEARCHWO2004006954
SEARCHWO2004043430
SEARCHWO2006013357
SEARCHWO2006013370

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- Thomas Österberg ET AL, "Development of a freeze-dried albumin-free formulation of recombinant factor VIII SQ", Pharmaceutical Research, US, (19970101), vol. 14, no. 7, doi:10.1023/A:1012199816852, ISSN 0724-8741, pages 892 - 898, XP055330200
EXAMINATION- CHI EVA Y ET AL, "Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, (20030901), vol. 20, no. 9, doi:10.1023/A:1025771421906, ISSN 0724-8741, pages 1325 - 1336, XP002475010
OPPOSITION- "Amphiphilic and Ionic Surfactants at electrlfled interfaces", WIECKOWSKI A., Interfacial electrochemistry, Marcel Dekker, (19990000), page 405, XP055654189
OPPOSITION- Anonymous, "Surfactants", Wikipedia, the free encyclopedia, (20170828), URL: https://en.wikipedia.org/wiki/Surfactant, XP055654192
OPPOSITION- EMEA, "ANNEX I and ANNEX II Allergan Marketing Authorization", EMEA, (20030000), pages 1 - 19, XP055654182
OPPOSITION- DasGupta B R et al, "Purification and amino acid composition of type A botulinum neurotoxin", Purification and amino acid composition of type A botulinum toxin, (19840000), vol. 22, no. 3, page 415, XP025528786
OPPOSITION- CHI ET et al., "Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation", Pharmaceutical Research, (20030901), vol. 20, no. 9, pages 1325 - 1336, XP002475010
OTHER- CHEUNG et al., "Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers", Biopharm. Drug Dispos., (20000901), vol. 21, no. 6, pages 211 - 219, XP008014526
OTHER- NORMAN et al., "Human serum albumin and Tween 80 as stabilizers of allergen solutions", Journal of Allergy and Clinical Immunology, (19781101), vol. 62, no. 5, pages 314 - 319, XP055702509
OTHER- OESTERBERG T. et al., "Development of a Freeze-Dried Albumin-Free Formulation of Recombinant Factor VIII SQ", Pharmaceutical Research, (19970700), vol. 14, no. 7, doi:10.1023/A:1012199816852, pages 892 - 898, XP009011546

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents